Other Income/Expenses (Net)

$137.03M

TTM · Period ending: Jun 30, 2026 · USD

Latest reported$137.03Mperiod endingJun 30, 2026

LGND TTM Other Income/Expenses (Net) (-$5.40M → $137.03M)

TTM Other Income/Expenses (Net)

High-resolution chart · PNG

LGND other income/expenses (net) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Ligand Pharmaceuticals Inc Other Income/Expenses (Net) — Trailing twelve months (TTM) (USD)
Period ending	Other Income/Expenses (Net) (USD)
Jun 30, 2001	-1,000,000
Mar 31, 2001	-1,312,000
Dec 31, 2000	-1,492,000
Sep 30, 2000	-8,459,000
Jun 30, 2000	-6,710,000
Mar 31, 2000	-6,346,000
Dec 31, 1999	-5,665,000
Sep 30, 1999	-15,165,000
Jun 30, 1999	-43,000,000
Mar 31, 1999	-43,000,000
Dec 31, 1998	-43,000,000
Sep 30, 1998	-92,100,000
Jun 30, 1998	-63,300,000
Mar 31, 1998	-62,400,000
Dec 31, 1997	-61,300,000
Sep 30, 1997	3,600,000
Jun 30, 1997	3,500,000
Mar 31, 1997	3,500,000
Dec 31, 1996	3,500,000
Sep 30, 1996	3,900,000
Jun 30, 1996	4,400,000
Mar 31, 1996	-1,900,000
Dec 31, 1995	-4,300,000
Sep 30, 1995	-6,900,000
Jun 30, 1995	-9,400,000
Mar 31, 1995	-5,400,000
Dec 31, 1994	-5,400,000